Friday, January 19, 2018 4:17:39 PM
It looks Capital Research and Management Company owns Pershing's shares also.
https://www.sec.gov/Archives/edgar/data/850693/000119312514196488/d723985dpren14a.htm
Security Ownership of Certain Principal Shareholders
Set forth below is the name and stock ownership of each person or group of persons known by the Company to own beneficially more than 5% of the outstanding shares of Company Common Stock, and is based on the Company Proxy Statement and information provided by the beneficial owner in subsequent public filing made with the SEC.
Name and Address of Beneficial Owners
Shares Beneficially
Owned Percent of
Class(1)
Capital Research Global Investors
17,472,533 (2) 5.87 %
40 East 52nd Street
New York, NY 10022
BlackRock, Inc.
17,416,972 (3) 5.85 %
40 East 52nd Street
New York, NY 10022
Pershing Square Capital Management, L.P.
888 Seventh Avenue, 42nd Floor
New York, NY 10019
28,878,638 (4) 9.71 %
PS Management GP, LLC
28,878,638 (4) 9.71 %
888 Seventh Avenue, 42nd Floor
New York, NY 10019
William A. Ackman
28,878,638 (4) 9.71 %
888 Seventh Avenue, 42nd Floor
New York, NY 10019
Valeant Pharmaceuticals International, Inc.
28,878,638 (5) 9.71 %
2150 St. Elzéar Blvd.
West Laval, Quebec, Canada, H7L 4A8
Valeant Pharmaceuticals International
28,878,638 (5) 9.71 %
400 Somerset Corporate Boulevard
Bridgewater, New Jersey 08807
(1) Based on 297,556,619 shares outstanding as of May 1, 2014 (exclusive of 10,035,841 shares held in treasury).
(2) Based on information provided pursuant to a statement on a Schedule 13G filed with the SEC on February 10, 2014 by Capital Research Global Investors, a division of Capital Research and Management Company. Capital Research Global Investors reported that it has sole voting power with respect to 17,472,533 shares and sole dispositive power with respect to 17,472,533 shares.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM